A clinical experience with Gengraf™ (Abbott cyclosporine) in de novo renal transplant recipients.

被引：0
|
作者：
Scandling, J
Rajagopalan, PR
Magee, J
Conti, D
Mendez, R
Bronson, D
Awni, W
Nabulsi, A
Hoffman, R
机构：
[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
[3] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[4] Albany Med Coll, Albany, NY 12208 USA
[5] Natl Inst Transplantat, Los Angeles, CA USA
[6] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
184
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [1] De novo anorectal cancers in renal transplant recipients.
    Rudich, SM
    Buell, JF
    Beebe, TM
    Gross, TG
    Hanaway, MJ
    Alloway, RR
    Trofe, J
    Woodle, ES
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 433 - 433
  • [2] Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplant recipients.
    Keown, P
    Ethgen, O
    Yang, XL
    Ricci, JF
    Kessabi, S
    Spaepen, S
    Annemans, L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 504 - 504
  • [3] Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience
    Li, J. T.
    Danguilan, R. A.
    Cabanayan-Casasola, C. B.
    Talusan-Tomacruz, Y.
    Ona, E. T.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) : 2211 - 2213
  • [4] Relationship Between Clinical Events and Everolimus Exposure at 12 Months in De Novo Renal Transplant Recipients.
    Shihab, F.
    Qazi, Y.
    Mulgaonkar, S.
    McCague, K.
    Patel, D.
    Peddi, V.
    Shaffer, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 217 - 217
  • [5] Study of a new generic cyclosporine, Consupren, in de novo renal transplant recipients
    Zafar, MN
    Ahmed, E
    Alam, A
    Akhtar, F
    Zafar, H
    Hashmi, A
    Naqvi, A
    Rizvi, A
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2480 - 2481
  • [6] De Novo Use of Everolimus With Elimination or Minimization of Cyclosporine in Renal Transplant Recipients
    Novoa, P. A.
    Grinyo, J. M.
    Ramos, F. J. P.
    Errasti, P.
    Franco, A.
    Aldana, G.
    Pefaur, J.
    Marti-Cuadros, A. M.
    Otero, A. B.
    Saval, N.
    Oppenheimer, F.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (09) : 3331 - 3339
  • [7] Renal Dysfunction at 12 Months Is Not Associated with Everolimus Exposure in De Novo Renal Transplant Recipients.
    Shihab, F.
    Qazi, Y.
    Mulgaonkar, S.
    McCague, K.
    Patel, D.
    Peddi, V.
    Shaffer, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 544 - 544
  • [8] Everolimus with Low-dose Cyclosporine in De Novo Renal Transplant Recipients: A Single Center Indian Experience
    Kesiraju, Sailaja
    Ch, Uma Maheswara Rao
    Paritala, Purna
    Reddy, V. S.
    Sahariah, S.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2015, 26 (06) : 1294 - 1299
  • [9] Significant Pharmacokinetic Interaction Between Everolimus and Tacrolimus in De Novo Renal Transplant Recipients.
    Chang, H. -P.
    Lee, C. -Y.
    Si, C. -C.
    Tsai, M. -K.
    Wu, F. -L. Lin
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 538 - 538
  • [10] Blinded Neoral C2 monitoring in de novo renal transplant recipients.
    Lake, KD
    Magee, JC
    Stodart, J
    Mclean, D
    Annesley, TM
    Cibrik, DM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 255 - 255
12345